Your browser doesn't support javascript.
loading
No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study.
Delrue, Maxime; Stépanian, Alain; Voicu, Sebastian; Nassarmadji, Kladoum; Sène, Damien; Bonnin, Philippe; Kevorkian, Jean-Philippe; Sellier, Pierre-Olivier; Molina, Jean-Michel; Neuwirth, Marie; Vodovar, Dominique; Mouly, Stéphane; Mebazaa, Alexandre; Mégarbane, Bruno; Siguret, Virginie.
Afiliação
  • Delrue M; Hematology Laboratory & Thrombosis unit, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France; EA 3518, Université Paris Cité, Paris, France.
  • Stépanian A; Hematology Laboratory & Thrombosis unit, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France; EA 3518, Université Paris Cité, Paris, France.
  • Voicu S; Department of Medical and Toxicological Critical Care, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France; INSERM UMRS-1144, Université Paris Cité, Paris, France.
  • Nassarmadji K; Department of Internal Medicine, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France.
  • Sène D; Department of Internal Medicine, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France.
  • Bonnin P; Laboratory of Clinical Physiology, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France; INSERM UMRS-1148, Université Paris Cité, Paris, France.
  • Kevorkian JP; Department of Diabetology-Endocrinology, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France.
  • Sellier PO; Department of infectious disease, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France.
  • Molina JM; Department of infectious disease, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France.
  • Neuwirth M; Hematology Laboratory & Thrombosis unit, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France; INSERM UMRS-1140, Université Paris Cité, Paris, France.
  • Vodovar D; INSERM UMRS-1144, Université Paris Cité, Paris, France; Paris Poison Control Center, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France.
  • Mouly S; INSERM UMRS-1144, Université Paris Cité, Paris, France; Department of Internal Medicine, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France.
  • Mebazaa A; Department of Anesthesiology and Critical Care, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France; INSERM UMRS-942, Université Paris Cité, Paris, France.
  • Mégarbane B; Department of Medical and Toxicological Critical Care, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France; INSERM UMRS-1144, Université Paris Cité, Paris, France.
  • Siguret V; Hematology Laboratory & Thrombosis unit, Université Paris Cité, Hospital group Lariboisière-Fernand Widal, APHP, Paris, France; INSERM UMRS-1140, Université Paris Cité, Paris, France. Electronic address: virginie.siguret@aphp.fr.
Chest ; 162(1): 226-229, 2022 07.
Article em En | MEDLINE | ID: mdl-35398318
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose Venosa / Tromboembolia Venosa / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Chest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose Venosa / Tromboembolia Venosa / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Chest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França